NCT02816775

Brief Summary

The intubation response to airway manipulation during direct laryngoscopy can cause hypertension, dysrhythmias and increased intracranial and intraocular pressures. This intense physiological response is proven to be associated with adverse outcomes especially in elderly patients. Increased QT dispersion is associated with increased risk of ventricular arrhythmias, which may increase the risk of sudden death caused by life-threatening arrhythmias. McGrath Videolaryngoscope would generate a lesser haemodynamic response than the conventional method of direct laryngoscopy. The objective of this study was to compare the hemodynamic response and QT during following tracheal intubation, using videolaryngoscope or direct laryngoscope to intubation. The postoperative airway morbidities is the investigators secondary outcome.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2016

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

June 20, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 29, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

August 30, 2022

Status Verified

August 1, 2022

Enrollment Period

4 months

First QC Date

June 20, 2016

Last Update Submit

August 25, 2022

Conditions

Keywords

hemodynamicsQT interval

Outcome Measures

Primary Outcomes (1)

  • mean blood pressure

    The patient's blood pressure should be measured and recorded at 5-minute intervals during the first 30 minutes of the operation.

    Change from baseline mean blood pressure at 30 minutes

Secondary Outcomes (3)

  • QT interval

    Change from baseline QT interval at 30 minutes

  • heart rate

    Change from baseline heart rate at 30 minutes

  • Number of participants with treatment-related adverse events as assessed by 4- point scale

    From extubation until postoperative 24 hours

Study Arms (2)

Group Laryngoscope

ACTIVE COMPARATOR

Group Laryngoscope; intubation will be made by Macintosh laryngoscope

Device: Macintosh Laryngoscope

Group Videolaryngoscope

ACTIVE COMPARATOR

Group Videolaryngoscope; intubation will be made by McGRATH Videolaryngoscope

Device: McGRATH Videolaryngoscope

Interventions

After induction of anesthesia, tracheal intubation will made by Macintosh Laryngoscope

Group Laryngoscope

After induction of anesthesia, tracheal intubation will made by McGRATH Videolaryngoscope

Group Videolaryngoscope

Eligibility Criteria

Age65 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • scheduled for elective surgery under general anesthesia requiring tracheal intubation

You may not qualify if:

  • hypertension,
  • cardiopulmonary disease,
  • diabetes mellitus,
  • a predicted problematic airway,
  • morbid obesity,
  • the use of medications known to affect blood pressure and heart rate as β-adrenergic blockers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Tempe DK, Chaudhary K, Diwakar A, Datt V, Virmani S, Tomar AS, Mohandas A, Mohire VB. Comparison of hemodynamic responses to laryngoscopy and intubation with Truview PCD, McGrath(R) and Macintosh laryngoscope in patients undergoing coronary artery bypass grafting: A randomized prospective study. Ann Card Anaesth. 2016 Jan-Mar;19(1):68-75. doi: 10.4103/0971-9784.173023.

Study Officials

  • Türkan Toğal, Prof.

    Inonu University Faculty of Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

June 20, 2016

First Posted

June 29, 2016

Study Start

June 1, 2016

Primary Completion

October 1, 2016

Study Completion

November 1, 2016

Last Updated

August 30, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share